IL9RP3: A Potential Drug Target and Biomarker (G729486)

Target Name: IL9RP3

NCBI ID: G729486

IL9RP3

Other Name(s): Interleukin 9 receptor pseudogene 3 | interleukin 9 receptor pseudogene 3

IL9RP3: A Potential Drug Target and Biomarker

Interleukin 9 (IL9) is a cytokine that plays a crucial role in the immune response and inflammation. The IL9 receptor, also known as IL9R, is a protein that is expressed in various tissues throughout the body, including the immune system, tissues, and organs. The IL9R has been identified as a potential drug target and biomarker for various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

IL9RP3, also known as Interleukin 9 receptor pseudogene 3, is a gene that encodes the IL9R protein. The IL9RP3 gene has been identified in various human genomes, and it is expressed in various tissues and organs, including the immune system, tissues, and organs. The IL9RP3 gene has been implicated in various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

The IL9RP3 gene has been associated with the development and progression of various diseases, including cancer. Studies have shown that individuals with certain genetic variations in the IL9RP3 gene are at an increased risk of developing cancer. For example, studies have shown that individuals with the SNP rs1821234 (IL9RP3) are at an increased risk of developing breast cancer.

The IL9RP3 gene has also been associated with various autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. Studies have shown that individuals with certain genetic variations in the IL9RP3 gene are at an increased risk of developing these autoimmune disorders. For example, studies have shown that individuals with the SNP rs686526 (IL9RP3) are at an increased risk of developing rheumatoid arthritis.

The IL9RP3 gene has also been associated with the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Studies have shown that individuals with certain genetic variations in the IL9RP3 gene are at an increased risk of developing these neurodegenerative diseases. For example, studies have shown that individuals with the SNP rs2653154 (IL9RP3) are at an increased risk of developing Alzheimer's disease.

Despite the potential association between the IL9RP3 gene and various diseases, the exact function of the IL9RP3 gene is not yet fully understood. Further research is needed to determine the exact function of the IL9RP3 gene and its potential as a drug target and biomarker.

In conclusion, IL9RP3 is a gene that has been associated with the development and progression of various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. Further research is needed to determine the exact function of the IL9RP3 gene and its potential as a drug target and biomarker.

Protein Name: Interleukin 9 Receptor Pseudogene 3

The "IL9RP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IL9RP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets